There is no single price, and good data are scarce. Healthdirect, the government health information service, says medicinal cannabis “may cost thousands of dollars each year”, depending on the illness, the product and the dose.1 That covers medicinal cannabis in general, not CBD oil alone.
We could not find a reliable source for the price of CBD oil per bottle or per milligram, so we do not quote one.
What makes up the cost?
The consultation. Fees are set by each practice, and we found no independent survey of them. The Royal Australian College of General Practitioners says “the patient is responsible for all costs associated with this access”.2 We could not confirm what Medicare rebate, if any, applies to these consultations.
The product. Most CBD products are unapproved medicines with no government subsidy, so the patient pays the full price set by the supplier and pharmacy.3
How much you take. Cost rises with dose. An Australian review of oral CBD found that reported benefits “became more clearly evident at doses ≥300 mg” a day, far above what a small bottle supplies for long.4 A prescriber sets the dose. Our CBD cost calculator shows how dose and bottle size change the monthly cost.
Why is Epidyolex different?
Epidyolex is the one CBD medicine on the Pharmaceutical Benefits Scheme (PBS). Its published price is $1,532.91 per 100 mL bottle. Eligible patients with Dravet syndrome or Lennox-Gastaut syndrome pay only the PBS co-payment, which is $25.00, or $7.70 with a concession card, as at 1 July 2026.35
Does anything else reduce the cost?
- Private health insurance. Some extras policies pay a limited amount towards non-PBS medicines. One insurer’s 2026 factsheet lists up to $100 per script with an annual cap of $600 on its top cover, and less on lower cover. Another pays only for TGA-approved products.67
- Veterans. The Department of Veterans’ Affairs funds medicinal cannabis case by case for some conditions.8
See is CBD covered by Medicare or the PBS?
Read the full guide: how much does CBD cost in Australia?
Footnotes
-
Healthdirect Australia. Medicinal cannabis, last reviewed February 2026. https://www.healthdirect.gov.au/medicinal-cannabis ↩
-
Royal Australian College of General Practitioners. Position statement: medicinal cannabis products. https://www.racgp.org.au/advocacy/position-statements/view-all-position-statements/clinical-and-practice-management/medical-cannabis ↩
-
Pharmaceutical Benefits Scheme. Cannabidiol, item 12467E. https://www.pbs.gov.au/medicine/item/12467E ↩ ↩2
-
Arnold JC, McCartney D, Suraev A, McGregor IS. The safety and efficacy of low oral doses of cannabidiol. Clinical and Translational Science, 2023. https://pubmed.ncbi.nlm.nih.gov/36259271/ ↩
-
Pharmaceutical Benefits Scheme. Fees, patient contributions and safety net thresholds. https://www.pbs.gov.au/info/healthpro/explanatory-notes/front/fee ↩
-
Health insurer factsheet on claiming for medicinal cannabis, 12 June 2026. https://www.hciltd.com.au/claiming-for-medicinal-cannabis ↩
-
Health insurer FAQ on claiming for medicinal cannabis. https://www.teachershealth.com.au/faqs/claiming/medication/claiming-for-medicinal-cannabis ↩
-
Department of Veterans’ Affairs. Updated medicinal cannabis framework. https://www.dva.gov.au/providers/provider-news/updated-medicinal-cannabis-framework-supports-safe-and-effective-prescribing-practices ↩
This page is general information, not medical or legal advice. Laws and evidence change; we show the date we last checked the facts at the top of every page. Talk to your doctor or pharmacist before starting, stopping or changing any medicine.
Didn't find what you needed? Ask us a question.
Get the monthly update
One short email a month: what changed in Australian CBD law, regulation and research, and which guides we updated. No advertising. Unsubscribe any time. (As of November 2026 we are collecting sign-ups; the first update has not been sent yet.)